Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:charge |
0
|
| gptkbp:form |
C62H86N12O16
|
| gptkbp:hasEnantiomer |
CHEBI:59778
|
| gptkbp:hasRole |
gptkb:antibiotic
antineoplastic agent |
| https://www.w3.org/2000/01/rdf-schema#label |
CHEBI:59776
|
| gptkbp:isConjugateBaseOf |
CHEBI:59775
CHEBI:59777 |
| gptkbp:isTautomerOf |
CHEBI:59779
|
| gptkbp:IUPACName |
2-amino-N,6-dimethyl-4,6,9,13,18,22,27,31-octaoxo-3,7,12,17,21,26,30-heptaazatricyclo[25.3.1.1^{5,9}]dotriaconta-1(31),2,5(32),7,10,12,15,17,20,22,25,27,29-dodecaen-16-yl}-N-methyl-L-valinamide
|
| gptkbp:mass |
1227.41
|
| gptkbp:name |
gptkb:actinomycin_D
gptkb:dactinomycin |
| gptkbp:partOf |
actinomycin group
|
| gptkbp:bfsParent |
gptkb:glyceraldehyde_3-phosphate
|
| gptkbp:bfsLayer |
7
|